File: '\\swfile\EmailIn\20241105 141245 Attachment 2024_11_05 Nova NR effective date of consolidation and name change.docx'

Nova Mentis Life Sciences Corp. Announces Effective Date of Share Consolidation and Name Change

VANCOUVER, BC / November 5, 2024 / Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces that, further to its news release dated October 31, 2024, the Company confirms the effective date for the consolidation of one (1) post-consolidation share for every five (5) pre-consolidation shares.

Effective at the opening on Friday, November 8, 2024, the shares of the Company will commence trading on the Canadian Securities Exchange on a consolidated basis under the name "Restart Life Sciences Corp." and stock symbol "HEAL".

Post-Consolidation Capitalization: Unlimited common shares with no par value of which approximately 29,663,732 common shares are issued and outstanding.

Transfer Agent: Olympia Trust Company

Trading Symbol: HEAL (new)

CUSIP Number: 76134J107 (new)

Record Date: November 8, 2024

About Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp (CSE: NOVA)("NOVA" or the "Company") a Canadian-based life sciences company listed on the Canadian Securities Exchange ("CSE").

Nova Mentis Life Science Corp.

Steve Loutskou

Chief Executive Officer

FOR FURTHER INFORMATION, PLEASE VISIT:

www: www.novamentis.co or email info@novamentis.co

Tel:(778) 819-0244

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. Forward-Looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include the future performance of Nova Mentis and her subsidiaries. Forward-Looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the business plans for Nova Mentis described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedarplus.ca.